2023 Q3 Form 10-Q Financial Statement

#000146310123000140 Filed on July 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $551.1M $711.1M $530.2M
YoY Change -13.18% 34.12% 67.75%
Cost Of Revenue $289.1M $387.8M $311.2M
YoY Change -21.19% 24.61% 65.3%
Gross Profit $262.0M $323.3M $219.0M
YoY Change -2.2% 47.64% 71.36%
Gross Profit Margin 47.55% 45.47% 41.31%
Selling, General & Admin $89.15M $92.80M $85.71M
YoY Change 1.66% 8.27% 87.58%
% of Gross Profit 34.03% 28.7% 39.14%
Research & Development $54.87M $60.04M $39.26M
YoY Change 24.18% 52.95% 72.87%
% of Gross Profit 20.94% 18.57% 17.92%
Depreciation & Amortization $19.50M $17.83M $15.25M
YoY Change 63.03% 16.93% 101.84%
% of Gross Profit 7.44% 5.51% 6.96%
Operating Expenses $144.0M $153.0M $125.0M
YoY Change 8.72% 22.45% 82.7%
Operating Profit $118.0M $170.3M $94.04M
YoY Change -12.89% 81.12% 58.31%
Interest Expense $2.196M $2.219M $2.168M
YoY Change -2.62% 2.35% -82.66%
% of Operating Profit 1.86% 1.3% 2.31%
Other Income/Expense, Net $19.36M $14.27M -$1.828M
YoY Change -1732.04% -880.85% -86.0%
Pretax Income $137.3M $184.6M $92.20M
YoY Change 2.23% 100.22% 99.14%
Income Tax $23.40M $27.40M $15.20M
% Of Pretax Income 17.04% 14.84% 16.49%
Net Earnings $114.0M $157.2M $76.98M
YoY Change -0.75% 104.21% 95.61%
Net Earnings / Revenue 20.68% 22.1% 14.52%
Basic Earnings Per Share $0.84 $1.15
Diluted Earnings Per Share $0.79 $1.08 $535.6K
COMMON SHARES
Basic Shares Outstanding 136.4M shares 137.0M shares 135.2M shares
Diluted Shares Outstanding 143.9M shares 145.1M shares 143.7M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.784B $1.800B $1.248B
YoY Change 25.87% 44.29% -4.91%
Cash & Equivalents $290.1M $278.7M $495.5M
Short-Term Investments $1.494B $1.522B $752.3M
Other Short-Term Assets $40.80M $35.81M $18.94M
YoY Change 82.56% 89.08% -45.5%
Inventory $174.1M $166.1M $130.3M
Prepaid Expenses
Receivables $560.3M $520.3M $312.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.599B $2.561B $1.736B
YoY Change 31.07% 47.51% 4.21%
LONG-TERM ASSETS
Property, Plant & Equipment $173.0M $151.7M $86.78M
YoY Change 88.46% 74.76% 37.28%
Goodwill $213.2M $214.3M $197.0M
YoY Change 9.05% 8.77% 221.27%
Intangibles $79.15M $85.96M $96.89M
YoY Change -12.95% -11.28% 113.37%
Long-Term Investments
YoY Change
Other Assets $215.3M $195.3M $129.2M
YoY Change 53.29% 51.2% 8.96%
Total Long-Term Assets $955.3M $905.1M $701.1M
YoY Change 33.58% 29.09% 61.27%
TOTAL ASSETS
Total Short-Term Assets $2.599B $2.561B $1.736B
Total Long-Term Assets $955.3M $905.1M $701.1M
Total Assets $3.554B $3.466B $2.437B
YoY Change 31.73% 42.21% 16.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.12M $79.08M $90.40M
YoY Change -2.92% -12.53% 10.05%
Accrued Expenses $434.8M $425.3M $197.9M
YoY Change 69.99% 114.88% 65.99%
Deferred Revenue $114.0M $109.2M $74.07M
YoY Change 43.24% 47.4% 34.46%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $94.67M $93.38M $88.43M
YoY Change 5.59% 5.6% 3.88%
Total Short-Term Liabilities $774.4M $743.6M $480.0M
YoY Change 40.74% 54.91% 34.61%
LONG-TERM LIABILITIES
Long-Term Debt $1.197B $1.201B $1.198B
YoY Change -0.14% 0.28% 28.93%
Other Long-Term Liabilities $53.76M $50.25M $23.86M
YoY Change 111.51% 110.57% 18.87%
Total Long-Term Liabilities $1.251B $1.251B $1.222B
YoY Change 2.18% 2.43% 28.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $774.4M $743.6M $480.0M
Total Long-Term Liabilities $1.251B $1.251B $1.222B
Total Liabilities $2.539B $2.493B $1.986B
YoY Change 21.62% 25.54% 30.99%
SHAREHOLDERS EQUITY
Retained Earnings $125.4M $189.5M -$251.2M
YoY Change -191.89% -175.44% 39.47%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $68.14M $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $1.015B $972.6M $451.0M
YoY Change
Total Liabilities & Shareholders Equity $3.554B $3.466B $2.437B
YoY Change 31.73% 42.21% 16.02%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $114.0M $157.2M $76.98M
YoY Change -0.75% 104.21% 95.61%
Depreciation, Depletion And Amortization $19.50M $17.83M $15.25M
YoY Change 63.03% 16.93% 101.84%
Cash From Operating Activities $145.8M $269.2M $200.7M
YoY Change -22.45% 34.19% 205.4%
INVESTING ACTIVITIES
Capital Expenditures $23.80M $44.00M -$8.691M
YoY Change -365.98% -606.29% -47.22%
Acquisitions
YoY Change
Other Investing Activities $9.000M -$20.05M $53.18M
YoY Change -102.74% -137.7% -365.39%
Cash From Investing Activities -$14.80M -$64.05M $44.49M
YoY Change -95.62% -243.97% -222.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -117.8M -212.2M -1.280M
YoY Change 2923.61% 16480.78% -99.38%
NET CHANGE
Cash From Operating Activities 145.8M 269.2M 200.7M
Cash From Investing Activities -14.80M -64.05M 44.49M
Cash From Financing Activities -117.8M -212.2M -1.280M
Net Change In Cash 13.20M -7.043M 243.9M
YoY Change -108.58% -102.89% -238.17%
FREE CASH FLOW
Cash From Operating Activities $145.8M $269.2M $200.7M
Capital Expenditures $23.80M $44.00M -$8.691M
Free Cash Flow $122.0M $225.2M $209.3M
YoY Change -38.06% 7.6% 154.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
68140000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
68140000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
972587000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
450999000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
972587000 usd
us-gaap Net Income Loss
NetIncomeLoss
304064000 usd
us-gaap Net Income Loss
NetIncomeLoss
128797000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34419000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28102000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
17705000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2703000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
629000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
131000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1200000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4140000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4025000 usd
us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
3498000 usd
us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
-129000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
113821000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
100861000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-26796000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
15617000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
83497000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27546000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16403000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55866000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
41993000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21352000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
107225000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10228000 usd
enph Increase Decrease In Warranty Obligations
IncreaseDecreaseInWarrantyObligations
49269000 usd
enph Increase Decrease In Warranty Obligations
IncreaseDecreaseInWarrantyObligations
22878000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
91800000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
38094000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
515475000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
303093000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66478000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21066000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27680000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1272908000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
60061000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
911804000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
193033000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-427582000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
84226000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
596000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4587000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
84635000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14807000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
200000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-284039000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10220000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1578000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-942000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-194568000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
376157000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
473244000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119316000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278676000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
495473000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8310000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2783000 usd
enph Purchase Of Property And Equipment Through Tenant Improvement Allowance
PurchaseOfPropertyAndEquipmentThroughTenantImprovementAllowance
0 usd
enph Purchase Of Property And Equipment Through Tenant Improvement Allowance
PurchaseOfPropertyAndEquipmentThroughTenantImprovementAllowance
748000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant estimates and assumptions reflected in the financial statements include revenue recognition, allowance for doubtful accounts, stock-based compensation, deferred compensation arrangements, inventory valuation, accrued warranty obligations, fair value of investments, debt derivatives, convertible notes and contingent consideration, fair value of acquired intangible assets and goodwill, useful lives of acquired intangible assets and property and equipment, incremental borrowing rate for right-of-use assets and lease liability. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ materially from those estimates due to risks and uncertainties, including uncertainty in the ongoing semiconductor supply and logistics constraints.</span></div>
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
420957 shares
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
133121000 usd
enph Contract With Customer Asset Amount Recognized
ContractWithCustomerAssetAmountRecognized
17658000 usd
enph Contract With Customer Asset New Contract Additions
ContractWithCustomerAssetNewContractAdditions
45592000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
161055000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
372360000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
51360000 usd
enph Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
142472000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
463472000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
55492000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
105360000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
97787000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
81815000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
213559000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
30993000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
34978000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
135118000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
114730000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
166111000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
149708000 usd
CY2023Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
219814000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
153916000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
16146000 usd
CY2023Q2 enph Vat Payable Current
VATPayableCurrent
35511000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5773000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5371000 usd
CY2023Q2 enph Business Combination Post Combination Expense Accrual Current
BusinessCombinationPostCombinationExpenseAccrualCurrent
0 usd
CY2022Q4 enph Business Combination Post Combination Expense Accrual Current
BusinessCombinationPostCombinationExpenseAccrualCurrent
9138000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
186000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
714000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14134000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20441000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
425285000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
295939000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
181254000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
33354000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
144736000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
58776000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
85960000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
118257000 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
26479000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45195000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
99541000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6794000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6285000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13588000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12071000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13585000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24538000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
23032000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
19473000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5046000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
85674000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
1663333000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
233000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7352000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
1656214000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
1370384000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
33000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10553000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
1359864000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1357928000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1352679000 usd
CY2023Q2 enph Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree
305405000 usd
CY2023Q2 enph Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Three
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree
303535000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
1663333000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
1656214000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
16344000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
11311000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
32515000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
20221000 usd
CY2023Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-10363000 usd
CY2022Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
17063000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-6635000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
21975000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
5092000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6590000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
13986000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
12471000 usd
CY2023Q2 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
3907000 usd
CY2022Q2 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
1828000 usd
enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
7452000 usd
enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
3343000 usd
CY2023Q2 enph Standard Product Warranty Accrual Change In Discount Rate
StandardProductWarrantyAccrualChangeInDiscountRate
31797000 usd
CY2022Q2 enph Standard Product Warranty Accrual Change In Discount Rate
StandardProductWarrantyAccrualChangeInDiscountRate
-9609000 usd
enph Standard Product Warranty Accrual Change In Discount Rate
StandardProductWarrantyAccrualChangeInDiscountRate
31797000 usd
enph Standard Product Warranty Accrual Change In Discount Rate
StandardProductWarrantyAccrualChangeInDiscountRate
-9609000 usd
CY2023Q2 enph Standard And Extended Product Warranty Accrual Other Period Increase Decrease
StandardAndExtendedProductWarrantyAccrualOtherPeriodIncreaseDecrease
-1912000 usd
CY2022Q2 enph Standard And Extended Product Warranty Accrual Other Period Increase Decrease
StandardAndExtendedProductWarrantyAccrualOtherPeriodIncreaseDecrease
-1031000 usd
enph Standard And Extended Product Warranty Accrual Other Period Increase Decrease
StandardAndExtendedProductWarrantyAccrualOtherPeriodIncreaseDecrease
-1874000 usd
enph Standard And Extended Product Warranty Accrual Other Period Increase Decrease
StandardAndExtendedProductWarrantyAccrualOtherPeriodIncreaseDecrease
-285000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
180715000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
96551000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
180715000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
96551000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
36686000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
29197000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
36686000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
29197000 usd
CY2023Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
144029000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1294497000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1290357000 usd
CY2022Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
67354000 usd
CY2023Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
144029000 usd
CY2022Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
67354000 usd
CY2023Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-10400000 usd
CY2022Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
17100000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-6600000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
22000000 usd
enph Product Warranty Obligations Change In Discount Rate Percent
ProductWarrantyObligationsChangeInDiscountRatePercent
0.05
enph Warranty Obligations At Fair Value Increase In Fair Value Liability Resulting From One Percentage Point Increase In Profit Element And Risk Premium
WarrantyObligationsAtFairValueIncreaseInFairValueLiabilityResultingFromOnePercentagePointIncreaseInProfitElementAndRiskPremium
1100000 usd
enph Warranty Obligations At Fair Value Decrease In Fair Value Liability Resulting From One Percentage Point Decrease In Profit Element And Risk Premium
WarrantyObligationsAtFairValueDecreaseInFairValueLiabilityResultingFromOnePercentagePointDecreaseInProfitElementAndRiskPremium
1100000 usd
enph Warranty Obligations At Fair Value Decrease In Fair Value Resulting From One Percentage Point Increase In Discount Rate
WarrantyObligationsAtFairValueDecreaseInFairValueResultingFromOnePercentagePointIncreaseInDiscountRate
9200000 usd
enph Warranty Obligations At Fair Value Increase In Fair Value Resulting From One Percentage Point Decrease In Discount Rate
WarrantyObligationsAtFairValueIncreaseInFairValueResultingFromOnePercentagePointDecreaseInDiscountRate
10300000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
93383000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
90892000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1201114000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1199465000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
90900000 usd
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
96400000 usd
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P12Y
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2416000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2052000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5773000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5371000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20311000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19077000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
26084000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
24448000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1788000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1325000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2852000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3752000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6691000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5940000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4252000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2882000 usd
CY2023Q2 enph Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
7857000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
31374000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5290000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
26084000 usd
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
633400000 usd
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P1Y6M
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54166000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53064000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54166000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53064000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
407600000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1464000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
92000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15375000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1372000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.85
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
227200000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1372000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
227200000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1372000 shares
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
227200000 usd
CY2023Q2 us-gaap Share Price
SharePrice
167.48
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1372000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P1Y6M
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.85
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1372000 shares
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.85
CY2023Q2 us-gaap Share Price
SharePrice
167.48
CY2023Q2 us-gaap Share Price
SharePrice
167.48
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27400000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
184600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59500000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
363600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
149600000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
76976000 usd
CY2023Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1651000 usd
CY2022Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
662000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
158842000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
77638000 usd
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1760000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3042000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145098000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143725000 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.15
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.57
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.09
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.54
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6227000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6721000 shares

Files In Submission

Name View Source Status
0001463101-23-000140-index-headers.html Edgar Link pending
0001463101-23-000140-index.html Edgar Link pending
0001463101-23-000140.txt Edgar Link pending
0001463101-23-000140-xbrl.zip Edgar Link pending
a2023q210-qexx311.htm Edgar Link pending
a2023q210-qexx312.htm Edgar Link pending
a2023q210-qexx321.htm Edgar Link pending
enph-20230630.htm Edgar Link pending
enph-20230630.xsd Edgar Link pending
enph-20230630_g1.jpg Edgar Link pending
exhibit101-amendmenttoflex.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
enph-20230630_lab.xml Edgar Link unprocessable
enph-20230630_def.xml Edgar Link unprocessable
enph-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
enph-20230630_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
enph-20230630_cal.xml Edgar Link unprocessable